This refers to tumors or cancers that start in the outer part of the adrenal glands. The adrenal glands sit on top of your kidneys and produce hormones.
Every report comes from a Lived member, sent anonymously.
Have you had Adrenalectomy for Adrenal Cortex Tumors?
Adrenal cortex tumors are growths that form in the outer layer, or cortex, of the adrenal glands, two small glands that sit on top of the kidneys. The cortex makes hormones the body depends on: cortisol, which helps regulate blood sugar, blood pressure and the response to stress; aldosterone, which balances salt, water and potassium; and sex hormones. Most of these tumors are adenomas, which are benign (not cancer). Many are found by chance on a CT or MRI scan done for another reason, and are then called adrenal incidentalomas. Adrenocortical carcinoma, a cancer of the adrenal cortex, is rare: in the United States it is diagnosed in roughly 0.5 to 2 people per million each year. Two questions matter most about any adrenal cortex tumor. Is it benign or cancerous? And is it functioning, meaning it makes too much of a hormone, or nonfunctioning? A benign, nonfunctioning adenoma usually causes no symptoms and may never need treatment. A functioning tumor can cause real harm through its hormones even when it is small and benign. Adrenocortical carcinoma is an aggressive cancer that needs specialist care. Symptoms depend on the hormone involved. Excess cortisol (Cushing syndrome) can cause weight gain in the face and trunk with thin arms and legs, a round red face, muscle weakness, high blood sugar and high blood pressure. Excess aldosterone causes high blood pressure, sometimes with muscle weakness or cramps, thirst and frequent urination. Excess androgens (male-type hormones) can cause facial hair growth, acne, a deeper voice or missed periods in women. A large tumor, which is more often a cancer, may cause a lump, fullness or pain in the abdomen or back.
Most adrenal adenomas have no identifiable cause, and nothing a person did is known to bring one on. Adrenocortical carcinoma also usually develops without a known reason. About 10 to 15% of cases are linked to inherited syndromes that raise cancer risk, including Li-Fraumeni syndrome (caused by an inherited change in the TP53 gene and associated with several cancers), Beckwith-Wiedemann syndrome, Carney complex, familial adenomatous polyposis and multiple endocrine neoplasia type 1 (MEN1). Having one of these syndromes does not mean a person will develop the cancer, and most people with adrenocortical carcinoma have none of them. The cancer has two age peaks, in children under 5 and in adults in their 40s and 50s, and it is somewhat more common in women. Children with adrenocortical carcinoma are treated differently from adults.
Evaluation of an adrenal tumor answers the two key questions: whether it could be cancer, and whether it makes excess hormone. Guidelines recommend both steps for every adrenal mass, including one found by chance. Imaging addresses the cancer question. On a CT scan taken without contrast dye, tissue density is measured in Hounsfield units. Benign adenomas usually contain fat, which makes them read low. A mass that looks uniform and measures 10 units or less is considered benign and needs no further imaging, whatever its size. A mass larger than 4 cm that looks uneven or measures above 20 units carries enough risk of cancer that surgery is usually recommended. Results in between are reviewed by a team of specialists and may call for further imaging, such as a contrast CT, MRI or PET scan. Blood and urine tests address the hormone question. The standard screen for excess cortisol is the 1 mg overnight dexamethasone suppression test. Dexamethasone is a steroid that normally signals the body to stop making cortisol; a person takes a small dose at night, and cortisol is measured in the morning. A level of 1.8 µg/dL (50 nmol/L) or lower is normal. A higher level in someone without the obvious features of Cushing syndrome is called mild autonomous cortisol secretion. People with high blood pressure or low potassium are also tested for excess aldosterone. Unless the CT shows a uniform mass of 10 units or less, metanephrines, breakdown products of adrenaline, are measured to rule out pheochromocytoma, a tumor of the inner part of the adrenal gland. It must be identified before any procedure, because it needs medicines that block its hormones beforehand to prevent dangerous complications during an operation. When cancer is suspected, sex hormones and their precursors are measured too, and a CT of the chest checks for spread. A needle biopsy is not part of the routine workup for suspected adrenocortical carcinoma; it is mainly reserved for masses that may be a cancer spread from somewhere else. A diagnosis of adrenocortical carcinoma is confirmed when a pathologist experienced with adrenal tumors examines the removed tumor.
Treatment depends on what the evaluation finds. A nonfunctioning adenoma with clearly benign imaging usually needs no treatment, and surgery is not typically recommended when it causes no symptoms. For a benign functioning tumor, the goal is to stop the hormone excess. An adenoma that causes Cushing syndrome, or one confirmed as the source of excess aldosterone, is usually removed in an operation called adrenalectomy, which for benign tumors is normally done laparoscopically or robotically through small incisions. With excess aldosterone, an adenoma seen on CT is not always the source, because the hormone can come from both glands. Before surgery, an experienced team usually confirms which side is responsible with adrenal vein sampling, a test that measures hormone levels in blood drawn from the vein of each adrenal gland. When both glands are involved, or surgery is not suitable or not wanted, medicines that block aldosterone's effects, such as spironolactone or eplerenone, are the main treatment for controlling blood pressure and potassium. Mild autonomous cortisol secretion calls for an individual decision: guidelines advise checking for and treating conditions that excess cortisol can worsen, such as high blood pressure and type 2 diabetes, and considering surgery when those conditions are present. Age, general health and personal preference also shape the choice. Adrenocortical carcinoma is treated differently. Guidelines recommend that every case be reviewed by a multidisciplinary team and that surgery be done by surgeons experienced in adrenal and cancer operations. Complete removal of the tumor, usually by open surgery that also takes surrounding fat and nearby lymph nodes, is the only treatment that can cure it. Mitotane (Lysodren) is a tablet that destroys adrenal cortex cells. It is offered after surgery when the risk of the cancer returning is high, and it is used for cancer that cannot be removed, often together with the chemotherapy drugs etoposide, doxorubicin and cisplatin. Its trade-offs are significant: fatigue, dizziness, stomach upset and changes in liver tests, cholesterol and blood counts are common, and its blood level is checked regularly. When the cancer has been removed completely and the risk of recurrence is lower, mitotane is no longer routinely given, because a randomized trial found it did not improve survival for that group. Mitotane can cause adrenal insufficiency (too little cortisol), so steroid replacement is usually part of treatment, sometimes at higher doses than usual. It can also harm a pregnancy, can make hormonal birth control (such as the pill) less effective, and stays in the body long after the last dose, so a nonhormonal method of contraception and any pregnancy plans need discussing with the care team. Radiation, ablation (destroying tumor tissue with heat or cold through a needle) and other local treatments can help control specific areas of spread, and clinical trials are testing immunotherapy and targeted drugs.
For most people with a benign, nonfunctioning adenoma, the tumor does not affect daily life. If the imaging was not clearly benign or hormone results were borderline, the care team may repeat scans or hormone tests over time to confirm that nothing has changed. After removal of a tumor that was making excess cortisol, the remaining adrenal gland has often been suppressed and needs time to recover, so temporary steroid replacement is common. About half of people who have surgery for mild autonomous cortisol secretion develop adrenal insufficiency afterward. Recovery often takes a few months but varies widely from person to person. Blood tests show when the replacement can be reduced and stopped. The care team then reassesses blood pressure, blood sugar and any other condition the excess cortisol may have affected. Adrenocortical carcinoma has a more serious course. The outlook depends mainly on the stage at diagnosis, whether the tumor could be removed completely and how abnormal the cells look under the microscope. It can be cured when found early, but it often returns even after successful surgery: in about 4 in 10 people it spreads to distant sites within two years. Follow-up is therefore intensive, with scans and hormone tests about every 3 months for the first two years, then every 4 to 6 months. When mitotane is given after surgery it usually continues for at least two years, with regular blood tests and visits along the way.
Arrange a medical evaluation if a scan has found an adrenal mass and hormone testing has not been done, or if you notice signs of hormone excess such as blood pressure that is hard to control, weight gain in the face and trunk with muscle weakness, or new facial hair and missed periods. A lump, fullness or ongoing pain in the abdomen or back is also worth checking. If you take mitotane or steroid replacement after adrenal surgery, contact your care team right away if you develop an infection, an injury or another illness, or if you cannot take your steroid tablets for any reason, because your treatment may need adjusting. If you take mitotane or steroid replacement, or have known adrenal insufficiency, call 911 or go to the emergency room for signs of adrenal crisis, a dangerous shortage of cortisol: severe weakness, confusion or fainting, severe abdominal or flank pain, or vomiting with dizziness or lightheadedness.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Adrenal Cortex Tumors is like, what's helped you, or ask the community a question.